our studies , which involved 25 autologous all recipients who received rhgm-csf and 27 controls similar for disease status ( remission or relapse ) and disease type ( b- or t-lineage ) differed from previous studies in one important aspect : the bone marrows were purged with 4-hydroperoxcyclophosphamide ( 4hc ) and anti-t or anti-b-cell lineage-specific antibodies before transplantation .
C0023449
all
C0005953
bone